ZVRA logo

ZVRA
Zevra Therapeutics Inc

24,246
Mkt Cap
$551.89M
Volume
4,687.00
52W High
$13.16
52W Low
$6.19
PE Ratio
6.29
ZVRA Fundamentals
Price
$9.40
Prev Close
$9.55
Open
$9.48
50D MA
$9.03
Beta
0.82
Avg. Volume
717,753.32
EPS (Annual)
$1.35
P/B
3.46
Rev/Employee
$1.75M
$385.27
Loading...
Loading...
News
all
press releases
Zevra Therapeutics (NASDAQ:ZVRA) Shares Gap Up - Still a Buy?
Zevra Therapeutics (NASDAQ:ZVRA) Shares Gap Up - Here's What Happened...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Zevra Therapeutics (NASDAQ:ZVRA) Now Covered by BTIG Research
BTIG Research began coverage on shares of Zevra Therapeutics in a research note on Monday. They issued a "buy" rating and a $23.00 target price on the stock...
MarketBeat·4d ago
News Placeholder
Zevra Therapeutics, Inc. $ZVRA Shares Bought by Kingdon Capital Management L.L.C.
Kingdon Capital Management L.L.C. lifted its holdings in Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) by 44.4% in the 3rd quarter, according to the company in its most recent disclosure with...
MarketBeat·4d ago
News Placeholder
Zevra Therapeutics (NASDAQ:ZVRA) Cut to "Hold" at Wall Street Zen
Wall Street Zen lowered Zevra Therapeutics from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·6d ago
News Placeholder
Analysts Set Expectations for ZVRA Q1 Earnings
Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for shares of Zevra Therapeutics in a research note...
MarketBeat·8d ago
News Placeholder
Zevra Therapeutics (NASDAQ:ZVRA) Sees Unusually-High Trading Volume - Time to Buy?
Zevra Therapeutics (NASDAQ:ZVRA) Sees Large Volume Increase - Here's Why...
MarketBeat·9d ago
News Placeholder
Brokers Offer Predictions for ZVRA Q3 Earnings
Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Investment analysts at HC Wainwright issued their Q3 2026 earnings estimates for shares of Zevra Therapeutics in a research report issued on...
MarketBeat·9d ago
News Placeholder
Why Zevra Therapeutics Stock Zoomed 21% Higher Today
Key PointsIt also posted 44% net revenue growth for the period...
Nasdaq News: Markets·10d ago
News Placeholder
Noteworthy Tuesday Option Activity: ZVRA, CHDN, GEV
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Zevra Therapeutics, Inc (Symbol: ZVRA), where a total volume of 13,148 contracts...
Nasdaq News: Markets·10d ago
News Placeholder
Why Is Zevra Therapeutics Stock Trading Higher Today?
Zevra Therapeutics jumped in Tuesday premarket trading after partnering with GeneDx to expand NPC genetic testing and reporting fourth-quarter earnings and revenue that beat estimates.read more...
Benzinga·10d ago
<
1
2
...
>

Latest ZVRA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.